Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Rocuronium for Postoperative Sore Throat
NCT03031808Phase 4Unknown
- Sponsor
- Ostfold Hospital Trust
- Start
- Oct 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in postoperative sore throat (POST) (3 arms), sponsored by Ostfold Hospital Trust. Primary endpoints: Sore Throat postoperative at 24 hours, Intubation conditions and 2 more. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative sore throat (POST)
Beyond the preview
Go deeper on NCT03031808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03031808.